Continuous glucose monitoring is not only about more readings. It is also about getting accurate alerts for current or upcoming low or high glucose events, consistently over the time of CGM system wear.
Highly accurate, also in the low glucose range.
Month by month, Eversense E3 has demonstrated exceptional accuracy and stable performance over the course of 180 days with a single sensor. Readings you can count on!
Make the most out of Eversense E3 exceptional accuracy
Eversense E3, with an overall MARD of 8.5%, is indicated to be used for treatment decisions without a confirmatory fingerstick (see disclaimer). This provides another level of trust and confidence from your Eversense E3 System.
While factory calibration might be possible for transcutaneous sensors lasting up to 2 weeks, a long-term implantable sensor lasting up to 180 days, essentially 12 times longer, requires calibration. This ensures the high accuracy of your Eversense E3 CGM System over the entire 6 months.
CONTOUR® NEXT BGM System has demonstrated highly accurate results2, going beyond the minimum accuracy requirements of the ISO 15197:2013.3
Are you sure your BGM meter does the same? If not, think about making a change today, for getting your E3 CGM system performance to its maximum potential.
Connect with us on social media and use #EversenseVibeTribe to join the
Eversense community and share your E3 experience!
We're here for you
Our Eversense team is dedicated and ready to provide the answers and support you need.
Was this content helpful?